The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHAOGEN INC | COM | 004449104 | 3,248 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
ALLERGAN PLC | SHS | G0177J108 | 11,954 | 71,700 | SH | SOLE | 71,700 | 0 | 0 | ||
AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 1,062 | 400,900 | SH | SOLE | 400,900 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 6,083 | 139,528 | SH | SOLE | 139,528 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 2,560 | 65,301 | SH | SOLE | 65,301 | 0 | 0 | ||
ATHENAHEALTH INC | COM | 04685W103 | 6,555 | 41,193 | SH | SOLE | 41,193 | 0 | 0 | ||
AVEO PHARMACEUTICALS INC | COM | 053588109 | 337 | 149,073 | SH | SOLE | 149,073 | 0 | 0 | ||
AVEO PHARMACEUTICALS INC | CALL | 053588909 | 158 | 70,100 | SH | Call | SOLE | 70,100 | 0 | 0 | |
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 5,454 | 57,900 | SH | SOLE | 57,900 | 0 | 0 | ||
CELLECTIS S A | SPONSORED ADS | 15117K103 | 548 | 19,388 | SH | SOLE | 19,388 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 1,340 | 10,875 | SH | SOLE | 10,875 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 6,025 | 1,158,700 | SH | SOLE | 1,158,700 | 0 | 0 | ||
CIGNA CORPORATION | COM | 125509109 | 13,154 | 77,400 | SH | SOLE | 77,400 | 0 | 0 | ||
CIVITAS SOLUTIONS INC | COM | 17887R102 | 568 | 34,649 | SH | SOLE | 34,649 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 5,349 | 438,422 | SH | SOLE | 438,422 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 1,912 | 48,800 | SH | SOLE | 48,800 | 0 | 0 | ||
INTEC PHARMA LTD JERUSALEM | SHS | M53644106 | 4,951 | 1,125,153 | SH | SOLE | 1,125,153 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 5,631 | 439,900 | SH | SOLE | 439,900 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 721 | 41,691 | SH | SOLE | 41,691 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 5,240 | 287,887 | SH | SOLE | 287,887 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 12,772 | 618,515 | SH | SOLE | 618,515 | 0 | 0 | ||
MYLAN N V | SHS EURO | N59465109 | 2,920 | 80,800 | SH | SOLE | 80,800 | 0 | 0 | ||
NABRIVA THERAPEUTICS PLC | SHS | G63637105 | 1,467 | 421,414 | SH | SOLE | 421,414 | 0 | 0 | ||
NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 716 | 194,663 | SH | SOLE | 194,663 | 0 | 0 | ||
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 1,476 | 144,752 | SH | SOLE | 144,752 | 0 | 0 | ||
PIERIS PHARMACEUTICALS INC | COM | 720795103 | 6,895 | 1,360,000 | SH | SOLE | 1,360,000 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 2,906 | 83,094 | SH | SOLE | 83,094 | 0 | 0 | ||
SABRA HEALTH CARE REIT INC | COM | 78573L106 | 2,149 | 98,906 | SH | SOLE | 98,906 | 0 | 0 | ||
SHIRE PLC | SPONSORED ADR | 82481R106 | 5,402 | 32,000 | SH | SOLE | 32,000 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM | 82640U107 | 5,347 | 1,806,562 | SH | SOLE | 1,806,562 | 0 | 0 | ||
TELIGENT INC NEW | COM | 87960W104 | 11,505 | 3,325,000 | SH | SOLE | 3,325,000 | 0 | 0 |